4,446
Total Claims
$186K
Drug Cost
2,443
Beneficiaries
$76
Cost/Patient
Peer Comparison vs. 110,156 Internal Medicine providers
-95%
Cost per patient vs peers
$76 vs $1,411 avg
-9%
Brand preference vs peers
9.6% vs 10.6% avg
Brand vs Generic
90% generic
Brand: 417 claims · $117K
Generic: 3,917 claims · $67K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Empagliflozin | 26 | $20K |
| Dabigatran Etexilate Mesylate | 48 | $14K |
| Atorvastatin Calcium | 513 | $7,067 |
| Tiotropium Bromide | 11 | $6,142 |
| Levothyroxine Sodium | 187 | $3,662 |
| Fluticasone Propion/Salmeterol | 22 | $3,510 |
| Insulin Nph Human Isophane | 36 | $3,450 |
| Amlodipine Besylate | 288 | $3,244 |
| Insulin Nph Hum/Reg Insulin Hm | 18 | $3,224 |
| Ciclesonide | 26 | $2,822 |
| Lisinopril | 235 | $2,709 |
| Insulin Nph Human Isophane | 17 | $2,575 |
| Losartan Potassium | 202 | $2,324 |
| Metformin Hcl | 174 | $2,053 |
| Insulin Glargine-Yfgn | 13 | $1,908 |
Prescribing Profile
70
Unique Drugs
Patient Profile
74
Avg Age
62%
Female
1.18
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About